DDR1 is a Novel Biomarker and Potential Therapeutic Target for the Combination Treatment of Liver Hepatocellular Carcinoma
Tianxing Li(Shanghai Changzheng Hospital), Beifang Ning(Shanghai Changzheng Hospital)
Cited by 3
Related Papers
Obese Individuals With and Without Phlegm-Dampness Constitution Show Different Gut Microbial Composition Associated With Risk of Metabolic Disorders
|Frontiers in Cellular and Infection Microbiology|2022|31